ATAI Life Sciences N.V. (NASDAQ:ATAI) price closed lower on Monday, April 15, dropping -10.00% below its previous close.
A look at the daily price movement shows that the last close reads $2.30. The company’s 5Y monthly beta was ticking 0.98. Taking into account the 52-week price action we note that the stock hit a 52-week high of $2.85 and 52-week low of $1.02. The stock added 23.21% on its value in the past month.
ATAI Life Sciences N.V., which has a market valuation of $343.68 million, is expected to release its quarterly earnings report May 07, 2024 – May 14, 2024.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give ATAI a short term outlook of 100% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Buy, while an average of long term indicators are currently assigning the stock as 100% Buy.
The overview shows that ATAI’s price is at present 2.15% off the SMA20 and 6.53% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 49.16, with weekly volatility standing at 10.82%. The indicator jumps to 10.60% when calculated based on the past 30 days. ATAI Life Sciences N.V. (NASDAQ:ATAI)’s beta value is holding at 0.89, while the average true range (ATR) indicator is currently reading 0.22.
An analysis of the ATAI Life Sciences N.V. (NASDAQ:ATAI) stock in terms of its daily trading volume indicates that the 3-month average is 1.62 million.
Current records show that the company has 166.03M in outstanding shares. The insiders’ percentage holdings are 30.44% of outstanding shares while the percentage share held by institutions stands at 8.22%. But the 46.81% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
